The GBM Drug Bank

The GBM Drug Bank is a drug design and informatics resource containing compounds that have been shown to be effective against glioblastoma in peer-reviewed literature.

In this, the first version, the GBM Drug Bank contains 986 compounds. Our objective is to cover the majority of GBM active compounds; additional compounds and search functions will be added in due course.

Access the Database

About Glioblastoma

Glioblastoma multiforme (GBM) is one of the most common and aggressive forms of brain cancer.

GBM has proven intransigent to current treatments. New therapies to tackle the disease are urgently needed.

Learn More

Other GBM Resources

Read more about the people behind the GBM Drug Bank

IOTA Pharmaceuticals (Cambridge UK) are the creators of the GBM Drug Bank

Learn More

The GBM Drug Bank was created as part of the WINDOW Consortium

Learn More

Learn more about the creation of the GBM Drug Bank

Learn More